Long-term monitoring of lung cancer patients
LUng CAncer focuS - Long Term Non-interventional Monitoring of Diagnostic and Treatment Patterns in Patients With Bronchogenic Carcinoma (LUCAS)
This study is tracking newly diagnosed lung cancer patients over five years to see how they are treated and cared for in different clinics.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ceska Lekarska Spolecnost Jana Evangelisty Purkyne z.s. Academic / other |
| Locations | 7 sites (Brno and 6 other locations) |
| Trial ID | NCT04228237 on ClinicalTrials.gov |
What this trial studies
This study involves the long-term non-interventional monitoring of newly diagnosed lung cancer patients in selected pneumology centers across the Czech Republic. It aims to gather data on the diagnostic and treatment patterns for bronchogenic carcinoma, focusing on the complexities of patient care in oncology. The monitoring will follow patients diagnosed from June 1, 2018, for up to 60 months, utilizing standard diagnostic and therapeutic procedures as determined by their physicians.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have been clinically diagnosed with lung cancer.
Not a fit: Patients who do not have a diagnosis of lung cancer or those diagnosed after the specified date will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the effectiveness of current diagnostic and treatment approaches for lung cancer, potentially improving patient outcomes.
How similar studies have performed: Other studies focusing on long-term monitoring of cancer patients have shown success in improving understanding of treatment patterns and outcomes, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: - clinical diagnosis of lung cancer (C34 in MKN classification) Exclusion Criteria:
Where this trial is running
Brno and 6 other locations
- University hospital Brno — Brno, Czechia (Recruiting)
- University hospital Hradec Kralove — Hradec Kralove, Czechia (Recruiting)
- University hospital Olomouc — Olomouc, Czechia (Recruiting)
- University hospital Plzen — Plzen, Czechia (Recruiting)
- University Thomayer hospital — Prague, Czechia (Recruiting)
- University hospital Motol — Praha 5, Czechia (Recruiting)
- University hospital Bulovka — Praha 8, Česká Republika, Czechia (Recruiting)
Study contacts
- Principal investigator: Martina Koziar Vasakova, Prof. — University Thomayer hospital Prague
- Study coordinator: Jana Alahakoon
- Email: jana.alahakoon@oaks.cz
- Phone: +420602350988
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.